Borromeo GL - Search Results

1

Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.

Sim IW, Borromeo GL, Tsao C, Hardiman R, Hofman MS, Papatziamos Hjelle C, Siddique M, Cook GJR, Seymour JF, Ebeling PR. Sim IW, et al. Among authors: borromeo gl. J Clin Oncol. 2020 Sep 10;38(26):2971-2980. doi: 10.1200/JCO.19.02192. Epub 2020 Jul 2. J Clin Oncol. 2020. PMID: 32614699 Clinical Trial.

2

Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.

Sim IeW, Sanders KM, Borromeo GL, Seymour JF, Ebeling PR. Sim IeW, et al. Among authors: borromeo gl. J Clin Endocrinol Metab. 2015 Oct;100(10):3887-93. doi: 10.1210/jc.2015-1794. Epub 2015 Aug 4. J Clin Endocrinol Metab. 2015. PMID: 26241323

3

Reply to Y. Myoken et al.

Sim IW, Borromeo GL, Seymour JF, Ebeling PR. Sim IW, et al. Among authors: borromeo gl. J Clin Oncol. 2021 Jan 10;39(2):173-174. doi: 10.1200/JCO.20.02906. Epub 2020 Dec 8. J Clin Oncol. 2021. PMID: 33290127 No abstract available.

4

Oral health risk factors for bisphosphonate-associated jaw osteonecrosis.

Tsao C, Darby I, Ebeling PR, Walsh K, O'Brien-Simpson N, Reynolds E, Borromeo G. Tsao C, et al. J Oral Maxillofac Surg. 2013 Aug;71(8):1360-6. doi: 10.1016/j.joms.2013.02.016. Epub 2013 Apr 11. J Oral Maxillofac Surg. 2013. PMID: 23582590

5

A review of the clinical implications of bisphosphonates in dentistry.

Borromeo GL, Tsao CE, Darby IB, Ebeling PR. Borromeo GL, et al. Aust Dent J. 2011 Mar;56(1):2-9. doi: 10.1111/j.1834-7819.2010.01283.x. Epub 2010 Dec 22. Aust Dent J. 2011. PMID: 21332734 Free article. Review.

6

A large case-control study reveals a positive association between bisphosphonate use and delayed dental healing and osteonecrosis of the jaw.

Borromeo GL, Brand C, Clement JG, McCullough M, Crighton L, Hepworth G, Wark JD. Borromeo GL, et al. J Bone Miner Res. 2014 Jun;29(6):1363-8. doi: 10.1002/jbmr.2179. J Bone Miner Res. 2014. PMID: 24443366 Free article.

7

Bisphosphonate exposure and osteonecrosis of the jaw.

Borromeo GL, Brand C, Clement JG, McCullough M, Crighton L, Hepworth G, Wark JD. Borromeo GL, et al. J Bone Miner Res. 2015 Apr;30(4):749-50. doi: 10.1002/jbmr.2428. J Bone Miner Res. 2015. PMID: 25808734 Free article. No abstract available.

8

Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.

Borromeo GL, Brand C, Clement JG, McCullough M, Thomson W, Flitzanis E, Wark JD. Borromeo GL, et al. BMC Musculoskelet Disord. 2011 Apr 10;12:71. doi: 10.1186/1471-2474-12-71. BMC Musculoskelet Disord. 2011. PMID: 21477374 Free PMC article.

9

Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Wong PK, Borromeo GL, Wark JD. Wong PK, et al. Among authors: borromeo gl. Rheumatol Int. 2013 Sep;33(9):2189-98. doi: 10.1007/s00296-013-2771-7. Epub 2013 May 8. Rheumatol Int. 2013. PMID: 23652790 Review.

10

Bisphosphonates, healthcare professionals and oral health.

Raj DV, Abuzar M, Borromeo GL. Raj DV, et al. Among authors: borromeo gl. Gerodontology. 2016 Mar;33(1):135-43. doi: 10.1111/ger.12141. Epub 2014 Jul 15. Gerodontology. 2016. PMID: 25039439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page